Primitive marrow lineage-negative rhodamine low and Hoechst low (LRH) stem cells isolated on the basis of quiescence respond to the cytokines thrombopoietin, FLT3L, and steel factor by synchronously progressing through cell cycle. We have now profi led the mRNA expression, as determined by real-time RT-PCR, of 47 hematopoietic or cell cycle-related genes, focusing on the variations in the cell cycle regulators with cycle transit. LRH stem cells, at isolation, showed expression of all interrogated genes, but at relatively low levels. In our studies, there was a good deal of consistency with regard to cell cycle regulatory genes involved in the G1/S progression point of LRH murine stem cells. The observed pattern of expression of cyclin A2 is consistent with actions at these phases of cell cycle. Minimal elevations were seen at 16 h with higher elevations at 24, 32, 40, and 48 h times encompassing S, G2, and M phases. CDK2 expression pattern was also consistent with a role in G1/S transition with a modest elevation at 24 h and more substantial elevation at 32 h. The observed pattern of expression of cyclin F mRNA with marked elevations at 16-40 h was also consistent with actions in S and G2 phases. Cyclin D1 expression pattern was less consistent with its known role in G1 progression. The alterations in multiple other cell cycle regulators were consistent with previous information obtained in other cell systems. The cycle regulatory mechanics appears to be preserved across broad ranges of cell types.
Introduction
H ematopoietic stem cell gene expression has been evaluated in different settings. We have focused on gene expression in a stem cell population purifi ed on the basis of quiescence and then induced to synchronously transit cell cycle by in vitro exposure to thrombopoietin (TPO), FLT3L, and steel factor. We have studied lineage-negative rhodamine 123 low Hoechst 33342 low (LRH) murine stem cells purifi ed on the basis of quiescence, utilizing depletion of lineage-positive cells and low staining with rhodamine 123 and Hoechst 33342 supra vital dyes [1] [2] [3] [4] . This stem cell population is separated on the basis of quiescence and is equivalent in long-term multilineage engraftment and progenitor generation to any of the other described marrow hematopoietic stem cell populations. Approximately 1 in 4 cells will repopulate and 80%-90% will give rise to multi-cytokineresponsive high-proliferative potential colony-forming cells (HPP-CFC) in vitro; the latter constituting one of the best surrogates for long-term engraftable stem cells [5] [6] [7] . We have previously shown that when this population of murine stem cells is exposed to IL-3, IL-6, IL-11, and steel factor in vitro in non-adherent fl asks that there is a reproducible and synchronous progression from dormancy through cell cycle [8] . The fi rst cycle from dormancy takes approximately 38-40 h to complete, while subsequent synchronous cycles (out to 5 cycles) are about 5-6 h in length. Previous studies have further established a number of reversible functional phenotype shifts with cycle progression. We have shown that short-and long-term engraftment [9, 10] , adhesion protein expression [11, 12] , cytokine receptor expression [13] , and marrow homing [14] and differentiation [15] show reversible shifts in phenotype. We have also shown that progenitor numbers vary inversely with engraftable stem cell content with cycle passage, terming this a stem cell inversion [16] . In work with murine LRH stem cells, employing 3′′ end PCR differential display analysis, we interrogated these supplemented with 5% heat-inactivated fetal calf serum (HI FCS; Hyclone, Logan, VT) and 1% penicillin/streptomycin (P/S; Life/Technologies/Gibco/BRL) using a mortar and pestle. The bone fragments were washed multiple times and the supernatant cell suspension and wash fractions fi ltered through a 40-μm nylon fi lter (Becton Dickinson, Franklin Lakes, NJ) to remove large bone particles. High lipid concentrations were reduced by centrifugation and resuspension of the cells in fresh buffer. The cells were incubated at 4°C for 5 min, so that small bone particles could settle out. The cell supernatant, depleted of these fragments, was then diluted to 10 7 cells/mL PBS with 5% HI FCS and 1% penicillin/streptomycin (PBS buffer).
LRH hematopoietic stem cell (HSC) purifi cation
A low-density fraction (1.320 ± 0.001 g/mL) of the whole bone marrow was isolated on Optiprep (Accurate Chemical and Scientifi c Corporation, Westbury, NY). The cells were lineage-depleted with the following primary rat antibodies: anti-B220, anti-MAC-1, anti-GR1, anti-Lyt-2, anti-L3T4, and Ter119 (BD PharMingen, San Diego, CA). Each batch of antibody was evaluated by fl ow cytometry analysis for the concentration, which resulted in the greatest shift in mean channel fl uorescence and/or the greatest percentage of positive cells detected. The optimal dilution for each antibody was at a fi nal concentration of 0.1 μg/10 6 cells (0.5 μg/10 6 cells for GR-1). After a 15-min incubation on ice, the labeled cells were washed in 1× Dulbecco's phosphate-buffered saline, without calcium or magnesium chloride (PBS; Invitrogen Corp., Carlsbad, CA), 5% heat-inactivated fetal calf serum (HI FCS; Hyclone, Logan, UT), and resuspended in PBS buffer. The cells were incubated with washed sheep anti-rat IgG-conjugated immunomagnetic polystyrene spheres (M-450 Dynabeads; Dynal, Lake Success, NY) at 4°C for 20 min by adding beads in a drop-like fashion to obtain a 1:5 bead to cell ratio. The beads were suspended in PBS buffer and, when added to the cells, resulted in 1.5 times the original cell volume. After the 20-min incubation, immunomagnetic bead-rosetted cells were removed using a magnetic particle concentrator (Dynal, MPC-6), and the unrosetted cells remaining in suspension were harvested by pipette. The lineage-depleted cells were labeled with rhodamine 123 at a concentration of 0.1 mg/mL and Hoechst 33342 at 10 mM. Cells were incubated in the dark for 30 min at 37°C, washed, and followed by an additional incubation for 20 min at 37°C, allowing time for effl ux of rhodamine. The last incubation was carried out twice before sorting. A population with both low expression of Hoechst and rhodamine fl uorescence was isolated by FACS using a BD Cytopia InFlux high-speed cell sorter (BD Biosciences San Jose, CA).
LRH cultures
LRH marrow cells were established in Tefl on (non-adherent) bottle cultures with DMEM + 15% HI FCS+ 1% P/S + 1% l-glutamine and cytokines at the following concentrations: thrombopoietin (TPO) 200 ng/mL, FLT3L 100 ng/mL, and steel factor 50 ng/mL. Cells were cultured at approximately 1 × 10 3 cells/mL in Tefl on bottles at 37°C, 5% CO 2 in a humidifi ed water-jacketed incubator (Forma Scientifi c, Marietta, OH). Gene expression was evaluated immediately (time 0, before culture), and in different experiments at 1, 2, 3, 16, 24, 32, 40, and 48 h. cells at isolation (quiescent) and compared gene expression to lineage-positive marrow cells. We identifi ed a set of 637 transcripts expressed in stem cells and not expressed in lineage-positive cells [17] . We evaluated a subset of these stem cell-specifi c genes in freshly isolated LRH stem cells (time 0) and in the same set of cells after 48 h of culture in IL-3, IL-6, IL-11, and steel factor. A major shift in gene expression was found with many genes active in LRH at time 0 but turned off at 48 h and other genes inactive at time 0 and turned on at 48 h. These observations indicated that there was a shifting gene expression profi le with cycle passage and that this correlated with changes in engraftment effi ciency. In more recent studies, we used real-time RT-PCR to determine gene expression through cycle in the "cycling" stem cell population of lineage-negative Sca-1+ marrow cells [18] . This population of putative stem cells has about 20% in S/G2/M at isolation, but progresses tightly through cell cycle upon exposure to IL-3, IL-6, IL-11, and steel factor. Conversely, LRH cells have a very low percentage of cells in S/G2/M at isolation. Here, we studied mRNA for a variety of cell surface epitopes and transcriptional regulators at different times in cytokine culture equating with different times in cell cycle. At isolation, these cycling stem cells expressed almost all cell surface markers and transcription factors studied, including receptors for granulocyte colony-stimulating factor (G-CSF), granulocyte-macrophage CSF, and IL-7. With cycle transit some transcripts, including CD34, CD45R, c-kit, Gata1, Gata2, Ikaros, and FOG showed stable expression over time, despite previously documented alterations in phenotype, while others evidenced variation of expression between and within experiments. The latter included Sca-1, Mac-1, c-fms, c-mpl, Tal-1, endoglin, and CD4. Altogether, these studies on lineage-negative Sca-1+ stem cells showed that stem cells at isolation expressed a wide variety of genes and, with cell cycle transit, some of the genes showed remarkable and variable (between experiments) shifts.
We have now characterized LRH cells progressing through cell cycle under cytokine stimulation as to expression of intrinsic cell cycle regulatory genes. This provides the fi rst cell cycle regulatory gene profi le of a population of primitive stem cell synchronously progressing through cell cycle.
Materials and Methods

Animals
Six-to eight-week-old congenic male B6.SJL-PtprcaPep3b/ Boy.J (B6.SJL) were purchased from Jackson Lab (Bar Harbor, ME). All animals were housed in micro-insulator cages, in a conventional clean facility for at least 1 week prior to experimental use. The animals in this Animal Care Committee approved study were maintained in accordance with the guidelines of the Institutional Animal Care and Use Committee of Rhode Island Hospital and recommendations in the Guide for the care and use of laboratory animals. All animals were 6-8 weeks of age at the time of bone marrow harvest.
Isolation of whole bone marrow
Six-to 8-week-old male mice were sacrifi ced. Bone marrow was collected from femurs, tibiae, iliac crests, and spines by grinding bones in phosphate-buffered saline (PBS) Homeo box A10, Gene mCG121167 Celera Annotation Mm00432448_m1 Cdkn1a
Cyclin-dependent kinase inhibitor 1A (P21), Gene mCG126433 Celera Annotation Mm00494449_m1 Cdkn2a
Cyclin-dependent kinase inhibitor 2A, Gene mCG123699 Celera Annotation Mm00443919_m1 Ccnc Cyclin C, Gene mCG4143 Celera Annotation Mm00485474_m1 Rad21 RAD21 homolog (Schizosaccharomyces pombe), Gene mCG19537 Celera Annotation Mm00484804_m1 Mcm2
Minichromosome maintenance defi cient 2 mitotin (Saccharomyces cerevisiae), Gene mCG130613 Celera Annotation Mm00479445_m1 Nfatc1
Nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1, Gene mCG18180 Celera Annotation Mm00487905_m1 Rad51 RAD51 homolog (S. cerevisiae), Gene mCG6194 Celera Annotation Mm00443947_m1 Cdk2
Cyclin-dependent kinase 2, Gene mCG18668 Celera Annotation Mm00440464_m1 Nek2
NIMA (never in mitosis gene a)-related expressed kinase 2, Gene mCG14118 Celera Annotation Mm00801867_m1 Mcm3
Minichromosome maintenance defi cient 3 (S. cerevisiae), Gene mCG119126 Celera Annotation Mm00432359_m1 Ccnd1
Cyclin D1, Gene mCG21251 Celera Annotation Mm00487888_m1 Rad17 RAD17 homolog (S. pombe), Gene mCG116114 Celera Annotation Mm00438064_m1 Ccna2
Cyclin A2, Gene mCG14064 Celera Annotation Mm00432385_m1 Ccnf Cyclin F, Gene mCG12800 Celera Annotation Mm00501741_m1 Myb Myeloblastosis oncogene, Gene mCG140750 Celera Annotation Mm00803251_m1 Rbl1
Retinoblastoma-like 1 (p107), Gene mCG21972 Celera Annotation Mm00514160_m1 E2f4 E2F transcription factor 4, Gene mCG141649 Celera Annotation Mm00483162_m1 Cdc25a
Cell division cycle 25 homolog A (S. pombe), Gene mCG2036 Celera Annotation Mm00803077_m1 Notch2
Notch gene homolog 2 (Drosophila), Gene mCG11101 Celera Annotation Mm00487954_m1 Rbl2
Retinoblastoma-like 2, Gene mCG126509 Celera Annotation Mm00624964_m1 E2f2 E2F transcription factor 2, Gene mCG5146 Celera Annotation Mm00482296_m1 Cdk5rap1 CDK5 regulatory subunit-associated protein 1, Gene mCG3682 Celera Annotation Mm00465434_m1 Pkd1
Polycystic kidney disease 1 homolog, Gene mCG12835 Celera Annotation Mm00432337_m1 Ccna1
Cyclin A1, Gene mCG19561 Celera Annotation Mm00437762_m1 B2m β2-Microglobulin, Gene mCG11606 Celera Annotation Mm00607939_s1 Actb Actin, beta, cytoplasmic, Gene mCG23209 Celera Annotation Mm99999915_g1 Gapdh Glyceraldehyde-3-phosphate dehydrogenase, Gene mCG1045551 Celera Annotation, Gene mCG4178 Celera Annotation, Gene mCG1030816 Celera Annotation, Gene mCG8723 Celera Annotation, Gene mCG125819 Celera Annotation, Gene mCG130520 Celera Annotation, Gene mCG19641 Celera Annotation, Gene mCG130428 Celera Annotation, Gene mCG142399 Celera Annotation, Gene mCG114986 Celera Annotation, Gene mCG1217 Celera Annotation, Gene mCG115979 Celera Annotation, Gene mCG112896 Celera Annotation, Gene mCG1037 Celera Annotation, Gene mCG121685 Celera Annotation, Gene mCG9609 Celera Annotation, Gene mCG19420 Celera Annotation, Gene mCG130206 Celera Annotation, Gene mCG117943 Celera Annotation, Gene mCG120614 Celera Annotation, Gene mCG133580 Celera Annotation, Gene mCG114112 Celera Annotation, Gene mCG134295 Celera Annotation, Gene mCG115100 Celera Annotation, Gene mCG113945 Celera Annotation, Gene mCG7218 Celera Annotation, Gene mCG49966 Celera Annotation, Gene mCG116755 Celera Annotation Mm00448463_m1 Ptprc Protein tyrosine phosphatase, receptor type, C, Gene mCG5383 Celera Annotation Mm00440310_m1 Mpl
Myeloproliferative leukemia virus oncogene, Gene mCG8865 Celera Annotation Mm00438996_m1 Flt3
FMS-like tyrosine kinase 3, Gene mCG121644 Celera Annotation Mm00438328_m1 Csf2
Colony-stimulating factor 2 (granulocyte-macrophage), Gene mCG13784 Celera Annotation Mm00432735_m1 Csf3r
Colony-stimulating factor 3 receptor (granulocyte), Gene mCG10884 Celera Annotation Mm00438331_g1 Csf2ra
Colony-stimulating factor 2 receptor, alpha, low-affi nity (granulocyte-macrophage), Gene mCG20697 Celera Annotation Mm00492300_m1 Gata2
GATA-binding protein 2, Gene mCG130615 Celera Annotation Mm00484678_m1 Gata1
GATA-binding protein 1, Gene mCG3964 Celera Annotation Mm00801891_m1 Nfe2
Nuclear factor, erythroid-derived 2, Gene mCG15671 Celera Annotation Mm00456421_m1 Ikzf1
IKAROS family zinc fi nger 1, Gene mCG3994 Celera Annotation housekeeper gene, β2-microglobulin, as indicated by cycle threshold (CT) values in multiple experiments at time 0 and after various times of cytokine culture. The relative reproducibility is shown by the very tight standard errors. Test values were all normalized to β2-microglobulin expression values.
In order to present fold differences that varied over a wide range especially when the comparator was very low, we have created a value range to encompass the varied fold differences and for ease of presentation. This is presented in Table 2 .
We have previously mapped the cell cycle status of LRH cells stimulated with thrombopoietin, FLT3L, and steel factor using propidium iodide [15] . At time 0, there are either very few or no LRH stem cells in S phase, and hence there is a highly synchronous progression through cycle. S phase progression probably occurs at around 15-16 h and, by 40 h, essentially all the LRH cells are in S phase.
In Figure 2 , we present the absolute ∆CT values for the cell cycle genes to give an indication of baseline gene expression. In general, at time 0 in freshly purifi ed LRH stem cells, expression of the cycle regulatory genes was low but quite varied. It is from this base that we are assessing the relative changes of gene expression over time.
Cyclin gene expression in LRH stem cells at different times in culture equating with different cell cycle points 
Cell cycle evaluation with propidium iodide staining
Gene analysis
Fold difference in gene expression was analyzed and expressed relative to the 0-h control. RNA was isolated from LRH cells at various points in cell cycle using the manufacturer's protocol (PicoPure™ RNA Isolation Kit, Arcturus Mt. View, CA). Reverse transcription was performed with the high-capacity cDNA reverse transcription kit (Applied Biosystems [ABI], Foster City, CA) using manufacturer's protocol for a 50-μL total reaction. Real-time PCR was performed using pre-developed Taqman Assays (ABI), targeted to mRNA in a 20-μL reaction mixture containing 2× Taqman Universal PCR Master Mix (ABI) and equal amounts of cDNA with nuclease-free water. Murine β2-microglobulin was used as an endogenous control. Samples were run, using the standard default thermal profi le (7900HT Sequence Detection System, ABI). TaqMan® custom array was used for larger samplings of the genes. Relative gene expression was calculated with the comparative CT method. In this method, the relative quantitation of the target gene is normalized to an endogenous control (β2-microglobulin) and is expressed relative to a calibrator sample (0-h control) as 2 −∆∆Ct or fold difference, where ∆Ct = Ct of target gene −Ct of endogenous control gene and ∆∆Ct = ∆Ct target gene − ∆Ct calibrator . Information on specifi c TaqMan ® assays is detailed in Table 1 .
Statistics
Data was evaluated using an unpaired Student's t-test.
Results
We fi rst established the stability of our gene expression system. Figure 1 shows expression of our control 
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progression point of LRH murine stem cells. Most striking was the highly reproducible and quite striking elevations of cyclins A2 and F with progression from G1 through S phase. Cyclin A2 binds and activates CDC2 and CDK2 promoting transitions at G1/S and G2/M phases [21] [22] [23] . The observed pattern of expression in 6 separate experiments is consistent with actions at these phases of cell cycle. No elevations were seen at 1, 2, and 3 h; minimal elevations were seen at 16 h with higher elevations at 24, 32, 40, and 48 h times encompassing S, G2, and M phases. CDK2 expression pattern was also consistent with a role in G1/S transition with a modest elevation at 24 h and more substantial elevation at 32 h. CDK2 interacts with a broad range of cyclins and also plays a role in chromosome stability [20] . Cyclin F belongs to the F box family of proteins that make up one of the 4 subunits of the ubiquitin ligase complex [24, 25] . This latter is involved in phosphorylation-dependent ubiquitination. In general, this is felt to be involved in control of cell cycle in S and G2 phases. This is also consistent with the observed pattern of are shown in Figure 3 . The striking elevations at cyclins A2 and F, at times of G1/S cycle transit and through the G2/M phases, are apparent. These changes were highly signifi cant (P values in legend). Expression of further cell cycle regulatory genes is presented in Figure 4 . Here, correlations with function are complex and sometimes not clear. However, many of the expression patterns continued to be consistent with the presumed place of these entities in cell cycle regulation.
Discussion
Cyclins and cyclin-dependent kinases play complex roles in the progression of cell cycle [19] , and their role may vary with different cell types or species under investigation. Much of this complexity is well-summarized in work by Sanchez and Dynlacht [20] .
In our studies, there was a good deal of consistency with regard to cell cycle regulatory genes involved in the G1/S [37] .
In a related vein, putative checkpoint/arrest regulators including Cdk2, Mdm2, and Sesn2 showed variable and relatively minor changes through cycle except possibly for SESn2 at 32 h [38] .
Finally, E2f1, E2f2, and E2f4 are lumped under regulation of cell cycle. There were relatively small elevations of E2f1 and E2f4 in S phase but, at most time points, its expression was below or at baseline, and it is not clear how these expressions fi t into the cell cycle picture of hematopoietic stem cells.
Evaluation of the absolute cycle values at time 0 indicated relatively low but quite variable expression of the cell cycle regulators in LRH stem cells.
Altogether, these data give us a profi le of cell cycle regulator mRNA expression with progress of primitive marrow hematopoietic stem cells through a cytokine-induced cell cycle transit. In general, based upon the described actions of these regulators, levels seen in the stem cells at different points in cycle were consistent with information obtained expression of cyclin F mRNA with no elevations at 1, 2, and 3 h and marked elevations at 16-40 h but not at 48 h when the cells have entered their next cycle transit. These fi ndings are consistent with fi ndings in multiple other cell systems.
Cyclin D1 also showed increased expression in S phase, albeit not as pronounced as was seen with cyclins A2 and F. It did not show increased expression at 16 h, suggesting a lack of involvement in the G1/S transition. D1 also showed an increase at one point in G1 (2 h). Cyclin D1 expression pattern was less consistent with its known role in G1 progression [20, 26] . Cyclin D has a role in repair of double-strand DNA breaks and mitosis. It did show moderately increased expression in S phase and through mitoses.
Cyclin C showed modest elevations in mid-to late S phase and through M phase consistent with its known role in mitotic growth [27, 28] .
Cyclin B2 showed modest elevations in S phase of the marrow stem cells [20, 29, 30] . Its probable role in G2/M transition was not really interrogated in these experiments.
Cyclin A1 showed marginal changes around baseline and, although this may be involved in control of cell cycle at the G1/S and G2/M transitions, the present data in murine marrow stem cells are more consistent with its role in control of germ-line meiotic cell cycle [31] .
Given the complexity of the cell cycle regulatory network, any division into specifi c classes is of necessity relatively arbitrary. We have grouped the cyclin gene expression, and presented this in Figure 4 . Cdkn2a, Myb, and Nfatc1 were grouped in G1 phase and G1/S transition. Nfatc probably has a major role with T cells [32] , and it was at baseline or depressed in the hematopoietic stem cells with cycle transit. Myb expression was modestly increased in S phase consistent with its known role in hematopoietic stem cell proliferation [33] . Cdkn2a or p16INK4a expression was variably up at Fold Difference (normalized) in multiple other cell systems. Particularly striking and highly reproducible were the marked elevations of expression of cyclins A2 and F coincident with transition from G1 to S phase. The cycle regulatory mechanics appear to be preserved across broad ranges of cell types.
Conclusion
Expression of cycle regulator genes at LRH stem isolation was very low and patterns of induction in general confi rmed data from other cell systems. The G1/S transition was characterized by reproducible induction of cyclins A2 and F gene expression. These data provide a cycle regulator gene expression profi le at different points in cycle transit of LRH stem cells.
